경상북도내과

2026 AACR-KCA Joint Conference on Precision Medicine in Cancer (1일차)

Name: 2026 AACR-KCA Joint Conference on Precision Medicine in Cancer (1일차)
Start: 2026-11-12
End: 2026-11-12
Location: 경주 화백컨벤션센터

6.0점 일반 6.0

주최: 대한암학회
일자: 2026-11-12
장소: 경주 화백컨벤션센터
수강료: 400,000원 구분별

수강료 구분별 상세보기

1. 사전등록: 1) 회원 15만원, 2)회원(업체), 비회원 20만원, 3)비회원(업체) 30만원, 4)전공의/대학원생 7만원,2. 현장등록: 1) 회원 20만원, 2)회원(업체), 비회원 30만원, 3)비회원(업체) 40만원, 4)전공의/대학원생 10만원

원문 기준 · 정확한 등록비는 KMA 신청 페이지에서 확인하세요.

평점 구성

총 평점6.0점

필수평점0점

일반평점6.0점

연수평점은 3년 24점·연 8점 상한·필수 2점 요건이 있습니다. 이 행사 들으면 올해 상한까지 몇 점? →

KMA 등록 페이지에서 신청 → 평점 계산기

세부 일정 (20강)

08:30~08:55 Beyond the microscope; AI-powered advances in precision oncology 300호 안상정(고려의대)
08:55~09:20 Imaging AI in breast cancer: Clinical impact beyond detection 300호 박은경(서울의대)
09:20~09:50 Reading the hidden code of cancer in routine pathology with AI: from tissue patterns to personalized cancer care 300호 Kun-Hsing Yu(Harvard Medical School, USA)
09:50~10:15 휴식 ()
10:15~10:40 MUTE-Seq: CRISPR-driven innovation for unmet needs in liquid biopsy 300호 허준석(고려의대)
10:40~11:05 Cellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology 300호 Maximilian Diehn(Stanford University, USA)
11:05~11:30 Extracellular vesicles as predictive biomarkers for ICI therapy: From nanoscale engineering to clinical applications 300호 부지윤(인하대)
11:30~11:55 Translational cancer research program 300호 Raghu Kalluri(UT MD Anderson Cancer Center, USA)
11:55~13:15 점심 ()
13:15~13:55 Innovating & Leveraging Integrated Active Reinforcement Learning Frameworks To Realize Precision Cancer Medicines 300호 Alex K. Shalek(MIT, USA)
13:55~14:05 휴식 ()
14:05~14:30 Development of NK cell-drug conjugates via membrane-immobilized anticancer therapeutics 300호 김교범(동국대)
14:30~14:55 Immune mechanisms of disease progression 300호 Irene M. Ghobrial(Dana-Farber Cancer Institute, USA)
14:55~15:20 Protein nanoparticle platforms for targeting surface molecules in cancer 300호 강세병(UNIST)
15:20~15:45 Patient-derived tumor models to understand breast tumor evolution 300호 Alana Welm(University of Utah Huntsman Cancer Institute, USA)
15:45~16:00 휴식 ()
16:00~16:25 Microbial metabolites control progression of cervical cancer 300호 정영태(서울의대)
16:25~16:50 The tumor microbiome and its effects on the response to immunotherapy 300호 Ravid Straussman(Weizmann Institute of Science, Israel)
16:50~17:15 Microbiome-based markers to improve the efficacy of cancer therapy 300호 이인석(연세대)
17:15~17:40 Relationship between the gut microbiota and the immune system 300호 Arielle Elkrief(Centre hospitalier de l’Université de Montréal, Canada)